Hikma Pharmaceuticals (LSE: HIK) is a multinational pharmaceutical company based in London, that manufactures branded and non-branded generic and in-licensed pharmaceutical products.

It was first listed on the London Stock Exchange in 2005 and is a constituent of the FTSE 250 Index.

It was founded in Jordan in 1978 by Samih Darwazah.

The Company was founded by Samih Darwazah in 1978 in Amman in Jordan.

In August 1996 it became the first Arab company to export pharmaceutical products to the United States.

It was first listed on the London Stock Exchange in 2005.

Recent acquisitions include Instituto Biochimico Pavese Pharma in Italy in 2005 and Jazeera Pharmaceutical Industries in Saudi Arabia in 2006.

In 2007 the Company went on to buy APM in Jordan, Alkan Pharma in Egypt, Thymoorgan in Germany, Ribosepharm in Germany and Multi-Source Injectables in USA in October 2010.

Source: Wikipedia